A case of antiprogrammed death-ligand 1 antibody-induced multisystem immune-related adverse events with pancreatitis and steroid-resistant sclerosing cholangitis

J Dig Dis. 2022 Jul;23(7):404-409. doi: 10.1111/1751-2980.13122.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Autoimmune Diseases* / drug therapy
  • B7-H1 Antigen
  • Cholangiopancreatography, Endoscopic Retrograde
  • Cholangitis, Sclerosing* / drug therapy
  • Humans
  • Pancreatitis* / chemically induced
  • Steroids

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Steroids